What is Expressable?
Founded in 2019, Expressable operates as an online speech therapy practice designed to bridge the gap between patients and specialized care. By leveraging a proprietary digital infrastructure, the company provides evidence-based interventions that are both accessible and personalized. In an industry historically fragmented by geographic and logistical barriers, Expressable has positioned itself as a critical service provider, utilizing its platform to streamline the delivery of speech-language pathology. The company's market position is bolstered by its commitment to clinical excellence and its ability to integrate seamlessly into the broader healthcare ecosystem, addressing a persistent demand for remote, high-touch therapeutic services.
How much funding has Expressable raised?
Expressable has raised a total of $45.5M across 3 funding rounds:
Angel/Seed
$4.5M
Series A
$15M
Series B
$26M
Angel/Seed (2021): $4.5M with participation from NextView Ventures, Lerer Hippeau Ventures, and AmplifyHer Ventures
Series A (2022): $15M led by NextView Ventures, Lerer Hippeau Ventures, Amplifyher Ventures, and F-Prime Capital Partners
Series B (2024): $26M supported by Digitalis Ventures, HarbourVest, and F-Prime Capital Partners
Key Investors in Expressable
Digitalis Ventures
Digitalis Ventures engineers solutions to unmet needs in health by leveraging deep technical, financial, and domain expertise. The company invests in biotechnology and technology-enabled solutions aimed at improving human and animal health while reducing costs.
HarbourVest
HarbourVest Partners provides clients with private markets investment solutions through fund investing, secondary, and direct co-investments, as well as commingled funds or separately managed accounts.
F-Prime Capital Partners
Founded in 2002, F-Prime Capital provides a team of investors, engineers, doctors, and scientists dedicated to investing in health care and technology for other companies.
What's next for Expressable?
With the successful closure of this Series B round, Expressable is well-positioned to accelerate its operational scaling and enhance its technological capabilities. The strategic focus will likely shift toward expanding its provider network, refining its clinical outcomes tracking, and deepening its integration with enterprise healthcare partners. As the telehealth landscape continues to evolve, the company's ability to maintain high standards of care while managing rapid growth will be the primary determinant of its long-term market dominance. The influx of capital provides the necessary runway to invest in product innovation and market penetration, ensuring that Expressable remains at the forefront of the digital speech therapy revolution.
See full Expressable company page
